Wexford Capital

Wexford Capital is an investment advisor based in Greenwich, Connecticut, with an additional office in Florida. Incorporated in 1994, the firm manages $6.5 billion in assets, focusing on hedge and private equity funds. Wexford Capital targets various asset classes, including private equity, agriculture, and real estate, primarily across North America.

Arthur H. Amron

Partner

Philip Bryan Braunstein

Partner

Charles Davidson

Chairman and CIO

Paul M. Jacobi

Partner

Joseph Michael Jacobs

President

Jay Maymudes

Partner and Chief Financial Officer

Aaron S. Meyer

Partner

James L. Rubin

Partner

Richard Shapiro

Partner

40 past transactions

Dig Inn

Series C in 2015
Dig Inn is a restaurant inspired by the seasons and the act of cooking. Classic recipes with lots of vegetables, expertly prepared, and sourced mindfully from farmers and producers we know and trust. Whether you’re looking for whole grains, naturally-raised meats, or fresh veggies, we’ve got a bowl with your name on it.

NxtPhase

Venture Round in 2001
NxtPhase develops, manufactures, and markets optical sensor and digital solutions for the electric power industry. The company’s products include optical current and voltage sensors; and opto-electronic modules that provide signal processing electronics for voltage and current transducers. NxtPhase was founded in 1993 and is headquartered in Vancouver, Canada.

Javelin Pharmaceuticals

Private Equity Round in 2005
Javelin Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and commercialization of products for the pain management market primarily in the United States and Europe. Its products focus on treating various pain disorders ranging from acute and episodic moderate-to-severe pain associated with breakthrough cancer pain, post-operative pain, post-trauma pain (orthopedic injury pain), procedural pain, and burn pain. The company's Dyloject (injectable diclofenac) received approval for marketing to treat post-operative pain in the United Kingdom and was licensed to Therabel Pharma N.V. for commercialization in the European Union and certain other countries outside the United States. Its products in the Phase 3 development stage in the U.S. include Dyloject (diclofenac sodium injectable), an injectable formulation of diclofenac and a prescription nonsteroidal anti-inflammatory drug that is used to treat post-operative pain due to its combination of effectiveness and tolerability; Ereska (intranasal ketamine), a proprietary nasal formulation; and Rylomine (intranasal morphine) for treatment of acute moderate-to-severe pain, including breakthrough pain. Javelin Pharmaceuticals has license agreements with Shimoda Biotech, Ltd. to develop and commercialize products related to a proprietary formulation of the injectable delivery of diclofenac; and West Pharmaceutical Services, Inc. to develop and commercialize intranasal morphine for the transmucosal delivery of morphine to humans and animals for the treatment of pain. The company was founded in 1998 and is based in Cambridge, Massachusetts.

Reverse Medical

Series B in 2010
Reverse Medical is a commercial-stage medical device company focused on revascularizing patients experiencing Acute Ischemic Stroke.

Specialty Renal Products, Inc.

Private Placement in 2018
Specialty Renal Products, Inc. designs, manufactures, and markets medical devices, including hemodiafiltration systems for the treatment of patients with end stage renal disease (ESRD). Its products are used in conjunction with the disposable tubing circuit sets used in treatments that provides continuous renal replacement therapy (CRRT). The company was founded in 2019 and is based in Nashville, Tennessee. Specialty Renal Products, Inc. operates as a subsidiary of Nephros, Inc.

Invuity

Venture Round in 2012
Invuity, Inc. develops visualization products for the less invasive surgical field applications. It offers BriteField Port System that provides illumination and visualization during minimally invasive procedures; and BriteField McCulloch retractor, which allows physicians to achieve visualization during surgery while using traditional techniques. Invuity, Inc. was formerly known as Spotlight Surgical Inc. The company was founded in 2004 and is headquartered in San Francisco, California.

ElMindA

Series C in 2015
ElMindA vision is to bring a paradigm change to the management of brain disorders and injuries, by transforming state of the art neuroscience into bed-side clinical practice. ElMindA has developed the BNA™ technology platform, which for the first time allows high resolution visualization and evaluation of the complex neuro-physiological interconnections of the human brain at work, capturing information on the composition, connectivity, synchronization and operation of brain networks.

Sophono

Series B in 2012
Sophono, Inc. develops and manufactures magnetic bone conduction hearing devices for patients with conductive hearing loss, mixed hearing loss, and single-sided deafness worldwide. It offers Alpha 2 MPO, a bone conduction hearing device that brings abutment-free bone conduction for the patients that lies under the skin. The company sells its products through clinics. The company was founded in 2009 and is based in Boulder, Colorado. As of March 26, 2015, Sophono, Inc. operates as a subsidiary of Medtronic plc.

Encorp

Series D in 2001
As the vanguard of distributed energy control, Encorp leverages the power of its advanced Gold Box™ to harness diverse forms of generation in today's New Energy Economy. Their energy-tech offerings and grid interconnection expertise advance energy savings, security and efficiency for federal, institutional and commercial installations. Their technologies transform the electric grid into a system that is cleaner, more cost effective, efficient, flexible, reliable, resilient and responsive. Encorp's elegant software and hardware seamlessly integrate a variety of distributed power resources, such as engine-generator sets, microturbines, fuel cells, combined heat and power (CHP or cogeneration), and energy storage devices. These power resources are critical in the operation of any enterprise that demands high-quality, reliable power at reasonable and predictable costs.

Mako Mining

Private Placement in 2020
Mako Mining operates as a publicly listed gold mining, development, and exploration company. It is developing its San Albino gold project in Nueva Segovia, Nicaragua. Mako’s primary objective is to bring San Albino into production quickly and efficiently while continuing the exploration of prospective targets in Nicaragua.

Epiphany

Series A in 2007
Epiphany Biosciences is developing both therapeutic products and diagnostic technologies that treat or prevent the spread of pathogenic viruses. Epiphany Biosciences is a privately-held company located in San Francisco, CA. To support its mission, Epiphany has assembled a world-class team of virologists, clinicians, and drug development experts with extensive pharmaceutical business experience to lead the company forward.

AZTherapies

Series C in 2019
AZTherapies, Inc., a biopharmaceutical company, discovers, develops, and commercializes products for the treatment of Alzheimer’s, stroke, ALS, and Parkinson’s diseases. It develops small molecule drugs that block the triggers of dementia, which interferes with the formation of disease-causing aggregates of amyloid-beta protein oligomers and amyloid plaques. AZTherapies, Inc. was founded in 2011 and is based in Boston, Massachusetts.

Rebound Therapeutics

Series B in 2017
Rebound has progressed rapidly over the past 18 months, having developed a unique array of devices to improve the procedural and clinical outcomes of many minimally invasive surgical procedures. In addition to rapid product development of its initial products, Rebound has assembled a world-class Scientific Advisory Board of leading MIS physicians, filed 14 patents to solidify its intellectual property platform and completed a series of pre-clinical studies supporting initial human-use, scheduled to begin soon.

GlobeImmune

Series C in 2007
GlobeImmune, operates as a biopharmaceutical company. It engages in developing and manufacturing Tarmogens, a targeted molecular immunotherapy for the treatment of cancer and infectious diseases. Its products include GI-3000, a Tarmogen for epidermal growth factor receptor over expressing tumors; GI-4000, a Tarmogen for mutated-Ras mediated cancers; GI-5005, a Tarmogen for chronic hepatitis C infection; GI-8000, a Tarmogen for influenza; and GI-10000 Targeted Ablation of Mutational Escape, a novel use of the Tarmogen platform that eliminates or prevents the emergence of mutated escape variants in patients receiving antiviral or targeted cancer therapies. GlobeImmune was founded in 1995 as Ceres Pharmaceuticals, Inc. The company is based in Louisville, Colorado.

Interventional Spine

Series C in 2007
Interventional Spine, Inc. engages in the design, development, production, and distribution of implantable devices for the spine to patients, surgeons, and hospitals worldwide. It offers Opticage expandable interbody fusion device; and PERPOS PLS System compressible facet fixation system. The company provides devices for podiatric and orthopedic trauma markets; and sells its products through a network of distributors. The company was formerly known as Triage Medical, Inc. and changed its name to Interventional Spine, Inc. in November 2006. Interventional Spine, Inc. was founded in 2000 and is based in Irvine, California. As of January 3, 2017, Interventional Spine, Inc. operates as a subsidiary of DePuy Synthes, Inc.

Mako Mining

Private Placement in 2019
Mako Mining operates as a publicly listed gold mining, development, and exploration company. It is developing its San Albino gold project in Nueva Segovia, Nicaragua. Mako’s primary objective is to bring San Albino into production quickly and efficiently while continuing the exploration of prospective targets in Nicaragua.

Viseon

Private Placement in 2020
Viseon, Inc. operates as a medical device company. It has developed the Voyant technology for use in both posterior and lateral access MIS spine procedures. The company’s technology offers a single-use disposable alternative to surgical microscopes, endoscopes and loupes, projecting the operative field onto a high definition flat panel display within the OR and to remote locations. Viseon, Inc. was incorporated in 2017 and is based in Irvine, California.

Shape Memory Medical

Series C in 2024
Shape Memory Therapeutics, Inc., a medical device company, focuses on the commercialization of medical devices based on shape memory polymer materials for minimally invasive (endovascular) applications. The company was founded in 2009 and is based in College Station, Texas.

Shape Memory Medical

Series B in 2017
Shape Memory Therapeutics, Inc., a medical device company, focuses on the commercialization of medical devices based on shape memory polymer materials for minimally invasive (endovascular) applications. The company was founded in 2009 and is based in College Station, Texas.

Tigris Pharmaceuticals

Series B in 2007
Tigris Pharmaceuticals, Inc., a biopharmaceutical company, develops therapeutic technologies for oncology and other areas of unmet medical need. Its products include Aminoflavone that is for the treatment of renal cell, breast, and lung cancer; GGTI-2418, a synthetic peptidomimetic inhibitor of geranylgeranyltransferase, which is for the treatment of lung, breast, pancreatic, and ovarian cancer; GFB-204, a calixarene derivative that is a potent and selective inhibitor of VEGFR and PDGFR tyrosine phosphorylation, which is for the treatment of prostate, pancreas, lung, breast, and renal cell. The company was founded in 2005 and is based in Bonita Springs, Florida.

Viseon

Series B in 2020
Viseon, Inc. operates as a medical device company. It has developed the Voyant technology for use in both posterior and lateral access MIS spine procedures. The company’s technology offers a single-use disposable alternative to surgical microscopes, endoscopes and loupes, projecting the operative field onto a high definition flat panel display within the OR and to remote locations. Viseon, Inc. was incorporated in 2017 and is based in Irvine, California.

Bonterra Resources

Private Placement in 2019
Bonterra Resources Inc., an exploration stage company, engages in the acquisition, exploration, and evaluation of natural resource properties in Canada. It explores primarily for gold deposits. The Company’s projects include the Gladiator Deposit, the Moroy Deposit and Bonterra Mill, and the Barry Deposit located in the provinces of Quebec, Canada. Bonterra Resources Inc. was incorporated in 2007 and is headquartered in Val-d’Or, Canada.
Specialty Renal Products, a subsidiary of Nephros, is focused on the development of medical device products for patients with renal disease, including a hemodiafiltration system for the treatment of patients with ESRD.SRP intends to develop and market a filtration system for use in conjunction with the disposable tubing circuit sets used in treatments that provide continuous renal replacement therapy (CRRT). The system will apply to patients who present in the intensive care unit with acute kidney injury (AKI). CRRT allows the clinician the ability to manage unstable AKI patients by offering slower ultrafiltration and solute removal. Some advantages with performing CRRT continuously (24 hours per day) include improved hemodynamic tolerance and more control over the total volumes given and removed from unstable AKI patients.

Via Airlines, Inc.

Merger/Acquisition in 2020
Via Airlines, Inc. operates an airlines providing chartered services. Via Airlines, Inc. was founded in 1997 and is headquartered in Maitland, Florida. On October 8, 2019, Via Airlines, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Middle District of Florida.

Grove Plaza LLC

Merger/Acquisition in 2016
Grove Plaza comprises real estate property. The asset is located in the United States.

Terraco Gold

Private Placement in 2019
Terraco Gold Corp., a precious metals royalty and exploration company, engages in the acquisition and exploration of mineral properties in the United States. It holds a 100% interest in the Almaden project, which consists of 12 leased patented lode mining claims, 208 unpatented lode mining claims, and approximately 280 acres of private fee ground located in Washington County, Idaho. The company also has royalty interests in the Spring Valley gold project and the Moonlight Project located in Pershing County, Nevada. Terraco Gold Corp. was incorporated in 1995 and is headquartered in Vancouver, Canada. As of August 19, 2019, Terraco Gold Corp. operates as a subsidiary of Sailfish Royalty Corp..

International Battery

Venture Round in 2008
International Battery (IB) is a green technology company providing environmentally friendly, large format, rechargeable lithium-ion cells and batteries – designed, developed and manufactured in the USA. IB provides next generation cell chemistries, electronics and advanced packaging technologies, broad design experience, and offers total solutions for rechargeable battery applications. There batteries can be used in a wide range of vehicular, industrial and military applications.

AZTherapies

Private Placement in 2019
AZTherapies, Inc., a biopharmaceutical company, discovers, develops, and commercializes products for the treatment of Alzheimer’s, stroke, ALS, and Parkinson’s diseases. It develops small molecule drugs that block the triggers of dementia, which interferes with the formation of disease-causing aggregates of amyloid-beta protein oligomers and amyloid plaques. AZTherapies, Inc. was founded in 2011 and is based in Boston, Massachusetts.

AZTherapies

Private Placement in 2020
AZTherapies, Inc., a biopharmaceutical company, discovers, develops, and commercializes products for the treatment of Alzheimer’s, stroke, ALS, and Parkinson’s diseases. It develops small molecule drugs that block the triggers of dementia, which interferes with the formation of disease-causing aggregates of amyloid-beta protein oligomers and amyloid plaques. AZTherapies, Inc. was founded in 2011 and is based in Boston, Massachusetts.

Vantage Sports

Seed Round in 2015
Vantage Sports, Inc. provides data and video analytics platform that uses data–gathering engines that produce in-depth look at a players’ performance. It offers sports content to enterprises, media, and fans. The company was incorporated in 2011 and is based in Bellevue, Washington. Vantage Sports, Inc. operates as a subsidiary of Competitive Analytics Consulting LLC.

Invuity

Series D in 2012
Invuity, Inc. develops visualization products for the less invasive surgical field applications. It offers BriteField Port System that provides illumination and visualization during minimally invasive procedures; and BriteField McCulloch retractor, which allows physicians to achieve visualization during surgery while using traditional techniques. Invuity, Inc. was formerly known as Spotlight Surgical Inc. The company was founded in 2004 and is headquartered in San Francisco, California.

Ellipse Technologies

Series C in 2011
Ellipse Technologies is focused on developing its implantable remote control technology platforms to include innovative treatments for a broad spectrum of spinal and orthopedic deformity applications, orthopedic trauma and fracture management. The initial products restore proper anatomic position and alignment of the spine and long-bones. MAGECâ„¢ MAGnetic Expansion Control System utilizes a novel motion-preserving, minimally-invasive technology that, through communication with an external magnetic field, can be non-invasively adjusted in an outpatient setting via remote control by the physician to correct spinal deformities. PRECICE System uses non-invasive adjustable intramedullary rods or bone plates to treat long-bone abnormalities, often the result of acute or chronic fractures. Ellipse is a privately-held medical device company located in California.

Viseon

Series A in 2017
Viseon, Inc. operates as a medical device company. It has developed the Voyant technology for use in both posterior and lateral access MIS spine procedures. The company’s technology offers a single-use disposable alternative to surgical microscopes, endoscopes and loupes, projecting the operative field onto a high definition flat panel display within the OR and to remote locations. Viseon, Inc. was incorporated in 2017 and is based in Irvine, California.

Bonterra Resources

Private Placement in 2020
Bonterra Resources Inc., an exploration stage company, engages in the acquisition, exploration, and evaluation of natural resource properties in Canada. It explores primarily for gold deposits. The Company’s projects include the Gladiator Deposit, the Moroy Deposit and Bonterra Mill, and the Barry Deposit located in the provinces of Quebec, Canada. Bonterra Resources Inc. was incorporated in 2007 and is headquartered in Val-d’Or, Canada.

OptiScan Biomedical

Private Equity Round in 2013
OptiScan Biomedical Corporation develops glucose monitoring systems for the intensive care unit (ICU)/CCU. It offers OptiScanner, an automated, bedside glucose monitoring system to assist healthcare providers manage the glucose level of critically ill patients. The company’s OptiScanner provides serial blood glucose measurements for a range of glucose concentrations. OptiScan Biomedical Corporation was founded in 1994 and is based in Hayward, California.

ICx Technologies

Series A in 2007
ICx Technologies is a leader in the development and integration of advanced sensor technologies for homeland security, force protection and commercial applications. Their proprietary sensors detect and identify chemical, biological, radiological, nuclear and explosive threats, and deliver superior awareness and actionable intelligence for wide-area surveillance, intrusion detection and facility security. They then leverage their unparalleled technical expertise and government funding to address other emerging challenges of their time ranging from a cleaner environment, alternative energy to life science.

Bonterra Resources

Post in 2020
Bonterra Resources Inc., an exploration stage company, engages in the acquisition, exploration, and evaluation of natural resource properties in Canada. It explores primarily for gold deposits. The Company’s projects include the Gladiator Deposit, the Moroy Deposit and Bonterra Mill, and the Barry Deposit located in the provinces of Quebec, Canada. Bonterra Resources Inc. was incorporated in 2007 and is headquartered in Val-d’Or, Canada.